Group files injunction to stop the fluoridation of Calgary's drinking water
A local group is trying to put a stop to fluoridation and has filed an injunction at the Alberta Court of King's Bench.
Safe Water Calgary believes fluoridation is a public health threat to Calgarians and says the risk of damage is not worth the dental benefit.
'It's not safe, it's not effective and we have good science to prove that,' said Dr. Robert Dickson, founder of Safe Water Calgary.
Adding fluoride to Calgary's drinking water has been a long contentious issue.
Calgarians most recently had their say in 2021 during a plebiscite, with 62 per cent voting in favour of reintroducing fluoride back into the water system.
Since then, the city has spent more than $28 million to upgrade both water treatments plants to be able to add in the fluoride.
Many dentists and dental organizations say research and data proves the benefits of fluoridated water.
However, Safe Water Calgary argues fluoride contains toxic substances and puts young children at risk.
'205,000 people back in 2021 are now dictating policy for 1.6 million people who didn't vote for it back then,' said Dickson.
The group is calling for a pause on fluoridation until an expert panel can look into it and all sides can agree on how the city should move forward.
The injunction will be heard in court Wednesday at noon with a rally held outside the building at the same time.
(With files from Mason DePatie)
Hashtags
Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles
National Post
3 hours ago
- National Post
Bausch + Lomb Announces Publication of Phase 3 Data on LUMIFY® Preservative Free Redness Reliever Eye Drops
Article content Phase 3 data show Bausch + Lomb's LUMIFY Preservative Free eye drops are as safe and effective as the original LUMIFY in reducing ocular redness The multicenter study with 380 participants confirmed that LUMIFY Preservative Free eye drops are non-inferior in efficacy to the original LUMIFY and have a favorable safety profile, offering an effective preservative-free option for sensitive eyes LUMIFY delivers noticeable results in one minute, lasts up to eight hours and is the No. 1 doctor-recommended redness reliever brand; more info at Article content VAUGHAN, Ontario — Bausch + Lomb Corporation (NYSE/TSX: BLCO), a leading global eye health company dedicated to helping people see better to live better, today announced Ophthalmology and Therapy has published results from a phase 3 study which assessed the efficacy and safety of LUMIFY Preservative Free redness reliever eye drops compared to LUMIFY redness reliever eye drops for reducing ocular redness. Article content 'Since launching in 2018, LUMIFY has been the No. 1 doctor-recommended redness reliever brand, known for delivering noticeable results in one minute and lasting up to eight hours,' 1 said John Ferris, president, Consumer, Bausch + Lomb. 'This study demonstrates that our new LUMIFY Preservative Free eye drops reduce redness quickly and are just as safe and effective as the original LUMIFY, providing a needed option for patients with eye sensitivities.' Article content In the randomized, active-controlled, multicenter study, 380 participants with ocular redness received either LUMIFY Preservative Free or LUMIFY, administered as a single drop four times daily for four weeks. The primary objective was to demonstrate that LUMIFY Preservative Free is non-inferior to LUMIFY in reducing ocular redness. The primary efficacy endpoint was investigator-assessed ocular redness score at eight timepoints from five-minutes to 240-minutes after drop administration on day one. The secondary objective of the study was to compare the safety of LUMIFY Preservative Free and LUMIFY. Article content The study met its primary objective, confirming that LUMIFY Preservative Free is statistically non-inferior to LUMIFY in reducing ocular redness in adults. A day one analysis of all 11 time points (one minute to 480 minutes post-administration) further supported these findings; and additional secondary efficacy endpoint data from one minute, 360 minutes and 480 minutes post-administration demonstrated that LUMIFY Preservative Free performs similarly to LUMIFY. The overall safety profile of LUMIFY Preservative Free was favorable and comparable to LUMIFY, and the occurrence of ocular treatment-emergent adverse events was similar in both treatment groups. In this clinical trial, LUMIFY Preservative Free demonstrated to have a low incidence of side effects, like rebound redness and loss of efficacy over time, when used as directed. Article content 'The results show that LUMIFY Preservative Free is a well-tolerated alternative option for consumers with ocular redness who have sensitivities to preservatives or are at increased risk of ocular surface disease,' said Melissa Toyos, MD, and partner, Toyos Clinic, Nashville, TN. Article content About the LUMIFY Brand Article content The LUMIFY brand began in 2018 with the U.S. launch of LUMIFY redness reliever eye drops. Before LUMIFY, redness relievers relied on the same ingredients for decades and were associated with well-known side effects. LUMIFY and LUMIFY Preservative Free are the only over-the-counter redness relievers formulated with low-dose brimonidine tartrate 0.025% that selectively target eye redness and offer excellent results with a lower risk of rebound redness and loss of efficacy when used as directed. In 2023, Bausch + Lomb introduced LUMIFY EYE ILLUMINATIONS™, a line of specialty eye care products specifically developed for the sensitive area around the eyes. In June 2025, Bausch + Lomb launched LUMIFY Preservative Free eye drops in the U.S. For more information on the LUMIFY brand, visit Article content Bausch + Lomb is dedicated to protecting and enhancing the gift of sight for millions of people around the world – from birth through every phase of life. Its comprehensive portfolio of approximately 400 products includes contact lenses, lens care products, eye care products, ophthalmic pharmaceuticals, over-the-counter products and ophthalmic surgical devices and instruments. Founded in 1853, Bausch + Lomb has a significant global research and development, manufacturing and commercial footprint with approximately 13,500 employees and a presence in approximately 100 countries. Bausch + Lomb is headquartered in Vaughan, Ontario, with corporate offices in Bridgewater, New Jersey. For more information, visit Article content Facebook Article content , Article content Instagram Article content , Article content LinkedIn Article content , Article content X Article content and Article content YouTube Article content . Article content References Article content ©2025 Bausch + Lomb. Article content Article content Article content Article content Article content Article content Contacts Article content Media Contact: Article content Article content Kristy Marks Article content Article content Article content
Toronto Sun
3 hours ago
- Toronto Sun
New Canadian gel shrinks chronic wounds doctors thought would never heal
An Ottawa patient who spent two years in hospital saw her wound begin to close for the first time, and she's not the only one. Julian Mulia and Megan Leslie are co-founders of Calgary-based NanoTess. Photo by NanoTess Inc. / HANDOUT Reviews and recommendations are unbiased and products are independently selected. Postmedia may earn an affiliate commission from purchases made through links on this page. Nancy Johnson was skeptical when her doctor asked if she would try a new treatment for a wound that had not healed in years. She had reason to be. This advertisement has not loaded yet, but your article continues below. THIS CONTENT IS RESERVED FOR SUBSCRIBERS ONLY Subscribe now to read the latest news in your city and across Canada. Unlimited online access to articles from across Canada with one account. Get exclusive access to the Toronto Sun ePaper, an electronic replica of the print edition that you can share, download and comment on. Enjoy insights and behind-the-scenes analysis from our award-winning journalists. Support local journalists and the next generation of journalists. Daily puzzles including the New York Times Crossword. SUBSCRIBE TO UNLOCK MORE ARTICLES Subscribe now to read the latest news in your city and across Canada. Unlimited online access to articles from across Canada with one account. Get exclusive access to the Toronto Sun ePaper, an electronic replica of the print edition that you can share, download and comment on. Enjoy insights and behind-the-scenes analysis from our award-winning journalists. Support local journalists and the next generation of journalists. Daily puzzles including the New York Times Crossword. REGISTER / SIGN IN TO UNLOCK MORE ARTICLES Create an account or sign in to continue with your reading experience. Access articles from across Canada with one account. Share your thoughts and join the conversation in the comments. Enjoy additional articles per month. Get email updates from your favourite authors. THIS ARTICLE IS FREE TO READ REGISTER TO UNLOCK. Create an account or sign in to continue with your reading experience. Access articles from across Canada with one account Share your thoughts and join the conversation in the comments Enjoy additional articles per month Get email updates from your favourite authors Don't have an account? Create Account The 74-year-old Ottawa woman had been in hospital for more than two years with a surgical wound that became infected and did not heal. Adverse reactions to antibiotics and treatments complicated her care. She eventually ended up at the special unit of Bruyère Health-Saint Vincent Hospital for patients with the most complex non-healing wounds. Specialists had used every treatment they could on the chronic abdominal wound that had become a barrier to improving Johnson's overall health and getting her out of the hospital. Every second day, she endured up to 45 minutes of sometimes painful dressing changes and treatments. But there was little improvement. Johnson, who spends her days reading, talking to family members and watching television in her hospital room, describes herself as a 'glass-half-full person.' But, like many patients living with chronic wounds, she had little expectation that things would improve any time soon. This advertisement has not loaded yet, but your article continues below. Still, she agreed to be part of a quality improvement project involving a wound-healing salve created by a Calgary health tech company. That company, NanoTess Inc., describes the treatment as 'a Health Canada-authorized medical device in the form of a liquid matrix that facilitates wound healing using catalytic technology.' It is a gel that transforms into a film, like a liquid bandage, that contains catalytic technology, which allows healing reactions to happen better and faster. Officials say they are not aware of any products in Canada using similar technology to heal wounds. The product, NanoSALV, had been attracting attention and raising hope in an area of health care in which hope is often in short supply and innovation is desperately needed. Your noon-hour look at what's happening in Toronto and beyond. By signing up you consent to receive the above newsletter from Postmedia Network Inc. Please try again This advertisement has not loaded yet, but your article continues below. Dr. Katrina DeZeeuw of Bruyère Health said a patient, who experienced extreme pain every time her dressings were changed, no longer felt pain. Photo by JULIE OLIVER / POSTMEDIA Dr. Katrina DeZeeuw, who treats patients with chronic wounds at Bruyère, admits she was also skeptical when the hospital's innovation team suggested she try the new product on patients with non-healing wounds for four weeks to see if it made a difference. 'In chronic wounds, changes don't often happen fast,' DeZeeuw said. 'If you take a wound that has been the same for a year and you are trying something on it and only giving it four weeks, I was worried that wouldn't be enough time.' She knew there was no such thing as a 'magic cure' for the complex patients she saw daily. For most people, cuts and wounds heal in a matter of days or weeks. But in some patients, especially those who are older or have other chronic conditions such as diabetes or poor circulation, healing can take significantly longer and unhealed wounds can become chronic, prone to infection, and even life-threatening. This advertisement has not loaded yet, but your article continues below. DeZeeuw began using the salve on eight patients, choosing those 'with the most challenging wounds I have in my patient population.' The patients all had wounds that had been present for at least one year and as long as three years. There had been no improvement for at least six to 12 months. Johnson was among them. After four weeks, something surprising happened. For most patients, the complex wounds began to look — and feel — different. DeZeeuw wasn't expecting to see 100 per cent healing in just four weeks, but what she saw through careful tracking was encouraging. On average, the wounds in those patients decreased in size by 26 per cent. Half of the patients saw their wounds decrease by between 30 and 47.5 per cent in four weeks. One patient, who experienced extreme pain every time her dressings were changed, no longer felt pain. This advertisement has not loaded yet, but your article continues below. After the initial four weeks, DeZeeuw continued using the treatment on five patients. Treatment was stopped on two others who had seen no improvement, and one patient died of unrelated causes. After eight weeks, the changes were even more profound. The average improvement was 49 per cent. Some wounds improved by as much as 80 per cent. Johnson's chronic wound was 24 per cent smaller after four weeks and 30 per cent smaller at eight weeks — the first significant change seen in years. 'I am really hopeful. These are really promising results,' DeZeeuw said. 'I am looking for the 100 per cent healed, and I wasn't expecting to see that in four weeks. But I am very hopeful that we will start to see those fully healed wounds.' This advertisement has not loaded yet, but your article continues below. Those are the kinds of results that have been seen elsewhere in Canada where the product is being used. In one case, a pressure injury that had been open for 13 years healed after being treated with the product for almost a year. In chronic wounds, changes don't often happen fast… These are really promising results. Katrina DeZeeuw To some extent, chronic wounds are the dark secret of the health system. They can be devastating to patients and their families and cost the health care system billions every year. But they are not widely talked about. There are no colourful ribbons or lavish fundraisers to raise money and awareness, but they have an oversized impact on patients, their families and the health system as a whole. The non-profit organization Wounds Canada calls them a silent epidemic. Wound care costs the Canadian health system $12 billion a year, according to Wounds Canada. The non-profit organization estimates that between 30 and 50 per cent of all health care involves treating wounds. That includes half of all nursing visits delivered in the community. And home care is generally unable to meet the demand. This advertisement has not loaded yet, but your article continues below. In a letter to Prime Minister Mark Carney in May, Wounds Canada CEO Mariam Botros urged the new government to invest more money in wound care, making sure it was available to all Canadians. She called it 'a 12-billion-dollar-a-year health and quality of life issue that will affect everyone in Canada at some point in their lives.' Better funding for training, supplies and preventative care would save Canada money in the long run, the organization says. It could also change lives. Chronic wounds have been a scourge of health care for millennia; signs of pressure sores have been found in Egyptian mummies, Florence Nightingale reportedly said that a bed sore was 'generally not the fault of the disease, but of nursing.' Still, chronic wounds continue to keep millions of patients in hospital, in treatment, in discomfort and at risk. This advertisement has not loaded yet, but your article continues below. Doing something to change the trajectory of chronic wounds became a mission of Julian Mulia, a chemical engineer originally from Mexico, who was inspired to look for solutions after losing both parents to chronic conditions, including managing wounds. He is chief operating officer of Calgary-based NanoTess. Co-founder Megan Leslie is CEO. Co-founders of NanoTess CEO Megan Leslie and COO Julian Mulia with NanoSALV. Photo by Nanotess / Handout The company describes its salve as a catalyst that uses the body's natural healing reactions to promote faster healing and reduce inflammation. 'Essentially, when a body is trying to heal a wound, it's like pushing a rock up a mountain. And a lot of us don't of the energy or resources to help make that (healing) reaction go to completion, which is where you get into chronic wound territory and your body just can't heal itself,' said Larissa Lalonde, strategy lead at the company. This advertisement has not loaded yet, but your article continues below. What the salve does, Lalonde said, is lower the energy it takes to heal the wound 'so that more of those healing reactions can take place faster and better.' During a provincial commercialization project funded by the CAN Health Network and conducted by Alberta Health Services and the University of Calgary, integrating the product into treatment improved wound healing in chronic wounds by 57.6 per cent. Those were wounds that had not healed for an average of more than one and a half years. Bruyère, which has the largest specialty wound treatment unit as well as the only complex care facility in eastern Ontario, is also part of the CAN Health Network, a federally funded agency that supports Canadian health-care innovation. Based on validation by the Alberta Health Service, it tried out the product earlier this year, and it now plans to expand its use, DeZeeuw said. This advertisement has not loaded yet, but your article continues below. 'My goal is to get it throughout Bruyère Health,' she said. 'It has the potential to really help a lot of people.' Other nearby hospitals and long-term care homes are also looking at it, she said, and it is being used across Canada. 'To my knowledge, there has not been a really significant breakthrough that has kind of flipped wound care on its head — at least since I have been in medical training,' DeZeeuw said. 'I am hopeful that this ends up being really helpful for at least a significant proportion of patients.' That includes many people in hospital beds and long-term care homes across the country suffering from chronic bed sores, diabetic foot ulcers and complex surgical incisions. In some cases, chronic wounds keep them bedridden or away from their homes and families. This advertisement has not loaded yet, but your article continues below. When a body is trying to heal a wound, it's like pushing a rock up a mountain. And a lot of us don't of the energy or resources to help make that (healing) reaction go to completion. Larissa Lalonde 'Often you suffer alone if you are dealing with a wound,' said Lalonde of NanoTess. 'It is not something that people typically talk openly about. But, when you do start to talk about it with friends or family, you realize how widespread this issue is.' The company was developed as a social enterprise 'committed to providing catalyzing healing for all.' That includes making sure the treatment is affordable and easy to use. The company also works with the homeless and other underserved populations who experience wounds. 'Our mission is to leave no one behind,' Lalonde said. The product is also available behind the counter at pharmacies across the country to treat all kinds of wounds. For patients like Johnson and others with chronic wounds, it represents a new chance to heal and, maybe a light at the end of a long tunnel. 'In the last little while, I have noticed more of a change,' Johnson said. 'It is still going to take a while, but it is getting better.' Read More MLB Sunshine Girls Opinion Toronto & GTA Toronto & GTA
CTV News
3 hours ago
- CTV News
Happy days for fundraising campaign in New Tecumseth
Alliston and Angus McDonald's McHappy Day raised $12,500 for the Stevenson Memorial Hospital Foundation (SMHF). In addition, SMHF received an extra $14,000 during its Because of YOU relaunch event, further strengthening its partnership and commitment to hospital redevelopment efforts. Together, this funding brings the total contributions from MacKinnon Restaurants, that owns McDonald's in both Alliston and Angus, to an impressive $200,000 to the Stevenson Memorial Hospital Foundation. 'We're incredibly proud to be part of a community that values and supports our local hospital. Every dollar raised during events like McHappy Day makes a real difference—it helps us provide the best possible care for our family, neighbours, and loved ones,' said Rory MacKinnon, owner/operator of McDonald's in Alliston and Angus. The Because of You campaign is an effort to raise funds from the community to help build a future of Stevenson Memorial Hospital. This project will triple the size of the hospital, provide expanded emergency care and advanced diagnostic imaging, including Stevenson's first MRI suite. Community funds will also be put toward modern inpatient facilities, and specialized surgical services, all designed to meet the evolving healthcare needs of the growing community. 'We are deeply grateful to McDonald's in Alliston and Angus for their incredible generosity and unwavering support during McHappy Day. 'Their contributions play a crucial role in our overall efforts to advance the construction of Stevenson's new facility, which will significantly enhance healthcare services for our community,' said Frank Cerisano, CEO for SMHF. 'This support is significant as it helps us progress towards our $80 million Because of YOU campaign goal, helping to ensure that every patient continues to receive the quality care they deserve today and for generations to come.'
